"Isoantigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigens that exist in alternative (allelic) forms in a single species. When an isoantigen is encountered by species members who lack it, an immune response is induced. Typical isoantigens are the BLOOD GROUP ANTIGENS.
| Descriptor ID |
D007519
|
| MeSH Number(s) |
D23.050.705
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Isoantigens".
Below are MeSH descriptors whose meaning is more specific than "Isoantigens".
This graph shows the total number of publications written about "Isoantigens" by people in this website by year, and whether "Isoantigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Isoantigens" by people in Profiles.
-
Yamazaki S, Patel M, Harper A, Bonito A, Fukuyama H, Pack M, Tarbell KV, Talmor M, Ravetch JV, Inaba K, Steinman RM. Effective expansion of alloantigen-specific Foxp3+ CD25+ CD4+ regulatory T cells by dendritic cells during the mixed leukocyte reaction. Proc Natl Acad Sci U S A. 2006 Feb 21; 103(8):2758-63.
-
Boruchov AM, Heller G, Veri MC, Bonvini E, Ravetch JV, Young JW. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest. 2005 Oct; 115(10):2914-23.
-
Notidis E, Heltemes L, Manser T. Dominant, hierarchical induction of peripheral tolerance during foreign antigen-driven B cell development. Immunity. 2002 Sep; 17(3):317-27.
-
Shawler DL, Bartholomew RM, Garrett MA, Trauger RJ, Dorigo O, Van Beveren C, Marchese A, Ferre F, Duffy C, Carlo DJ, Sherman LA, Gold DP, Sobol RE. Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine. Clin Exp Immunol. 2002 Jul; 129(1):99-106.
-
Eisen HJ. Targeting the alloimmune response for prevention of chronic graft loss: efficacy of new immunosuppressive drugs. Transplant Proc. 1997 Dec; 29(8A):29S-31S.
-
Gilman A, Auger JJ, Terry L, Flomenberg N, Baxter-Lowe LA. HLA-B14 subtypes and their influence on allorecognition. Tissue Antigens. 1996 Mar; 47(3):253-6.
-
Iwata M, Yagihashi A, Roat MI, Zeevi A, Iwaki Y, Thoft RA. Human leukocyte antigen-class II-positive human corneal epithelial cells activate allogeneic T cells. Invest Ophthalmol Vis Sci. 1994 Nov; 35(12):3991-4000.
-
Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994 Jan; 7(1):82-90.
-
Sanders H, McCue P, Graham SD. ABO(H) antigens and beta-2 microglobulin in transitional cell carcinoma. Predictors of response to intravesical bacillus Calmette-Guerin. Cancer. 1991 Jun 15; 67(12):3024-8.
-
Dupont B, Flomenberg N, Yang SY. Alloantigens stimulating graft-v-host disease. Transplant Proc. 1987 Dec; 19(6 Suppl 7):48-51.